BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

Huong D. Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K. Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis, Bingjian Feng, Saundra S. Buys, John L. Hopper, Melissa C. Southey, Andrea Tesoriero, Paul A. James, Fiona Bruinsma, Ian G. Campbell, Annegien Broeks, Marjanka K. SchmidtFrans B. L. Hogervorst, Matthias W. Beckman, Peter A. Fasching, Olivia Fletcher, Nichola Johnson, Elinor J. Sawyer, Elio Riboli, Susana Banerjee, Usha Menon, Ian Tomlinson, Barbara Burwinkel, Ute Hamann, Frederik Marme, Anja Rudolph, Ramunas Janavicius, Laima Tihomirova, Nadine Tung, Judy Garber, Daniel Cramer, Kathryn L. Terry, Elizabeth M. Poole, Shelley S. Tworoger, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Carl Blomqvist, Sofia Khan, Heli Nevanlinna, Liisa M. Pelttari, Kristiina Aittomäki, Ralf Butzow, EMBRACE, kConFab Investigators, Australia Ovarian Canc Study Grp, HEBON, GEMO Study Collaborators, OCGN, PRostate Canc Assoc Grp

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number315
JournalJournal of the National Cancer Institute
Volume108
Issue number2
Number of pages10
ISSN0027-8874
DOIs
Publication statusPublished - Feb 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • SINGLE-NUCLEOTIDE POLYMORPHISMS
  • GERM-LINE MUTATION
  • PANCREATIC-CANCER
  • SUSCEPTIBILITY GENE
  • DNA RECOMBINATION
  • ESTROGEN-RECEPTOR
  • FAMILY-HISTORY
  • FANCONI-ANEMIA
  • LOCI
  • CONSORTIUM
  • 3123 Gynaecology and paediatrics
  • 3122 Cancers

Cite this